HPV Vaccine: Protect Against 90% of Cervical Cancer in Peru
Table of Contents
Peru has taken a monumental step in safeguarding the health of its youth and combating cervical cancer with the nationwide rollout of a free, nonavalent Human Papillomavirus (HPV) vaccine for all girls and boys up to 18 years old. This expansion,announced by the Ministry of Health (Minsa),promises to significantly reduce rates of HPV-related cancers and improve health equity across the country.
A Landmark Decision for Public Health
the decision to include the nonavalent HPV vaccine in the national immunization program represents a fundamental advancement in preventative healthcare, especially for vulnerable populations. Karla Ruiz de Castilla, director of the Esperanta Patient Association, emphasized the importance of this move, stating, “Ensuring that the vaccine reaches those who need it most is key to saving lives.” The vaccine will be readily accessible free of charge in schools, health centers, and through community campaigns, removing financial barriers to protection.
This expansion addresses a critical public health need.Cervical cancer is currently the leading cause of cancer death among women in Peru, surpassing even breast cancer. In 2022,a staggering 2,545 deaths were attributed to cervical cancer,compared to 1,951 from breast cancer,according to the report “Reduce the equity gap: oncological attention for women in Peru” by Economist Impact. The disease disproportionately affects young women, those with lower incomes, and residents of rural areas and indigenous communities, where access to healthcare is frequently enough limited.
How to Access the HPV Vaccine
Protecting your child is now easier than ever. Here’s what you need to know about accessing the HPV vaccine:
target Population: All girls and boys up to 18 years of age.
Vaccination Locations: The vaccine is available at health centers nationwide, within schools, and during community vaccination campaigns. Required Documents: Please bring your child’s DNI (national identification document) and vaccination card to ensure proper recording of doses.
The nonavalent HPV vaccine offers broader protection than previous versions. It targets nine strains of the virus, covering approximately 90% of cervical cancers and protecting against additional cancers, including those of the vulva, vagina, penis, anus, and oropharynx (back of the throat, including base of the tongue and tonsils).
The inclusion of this vaccine in the Pan American Health Institution (PAHO) rotary fund has been instrumental in making it affordable and readily available to Peru. This ensures that all doses meet the stringent quality standards set by the World Health Organization (WHO).
Addressing Health Disparities and Saving Lives
The expanded HPV vaccination program is a crucial component of Peru’s primary cancer prevention strategy. by proactively immunizing adolescents, the country is working towards more equitable and effective coverage, particularly for those most at risk.
The economist Impact report highlights that limited access to vaccination is a meaningful driver of health disparities. This new initiative directly addresses this challenge,bringing preventative care to communities that need it most.
This proactive approach not only saves lives but also reduces the burden on the healthcare system by decreasing the incidence of HPV-related cancers and the need for costly treatments. Investing in prevention is an investment in a healthier future for Peru.
Resources and Further Information
They estimate that HPV vaccination goal must exceed 1.1 million doses: https://gestion.pe/peru/estiman-que-meta-de-vacunacion-contra-el-vph-debe-superar-los-11-millones-de-dosis-ministerio-de-salud-voces-ciudadanas-ley-de-presupuesto-noticia/
* They warn that resources for HPV vaccination in adolescents are insufficient: [https://gestion.pe/peru/politica/advierten-que-son-insuficientes-los-recursos-para-vacunacion